Efficacy of Bofu‐tsusho‐san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance
- 1 September 2004
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 31 (9) , 614-619
- https://doi.org/10.1111/j.1440-1681.2004.04056.x
Abstract
1. In the present study, we conducted the first randomized, double-blind, placebo-controlled study of bofu-tsusho-san (BF), an oriental herbal medicine (24 mg/day ephedrine in Ephedrae Herba and an efficacy equivalent of 280 mg caffeine, judging from the phosphodiesterase-inhibitory effect of Glycyrrhizae Radix, Forsythiae Fructus and Schizonepetae Spica and another 14 crude drugs) in obese women with impaired glucose tolerance (IGT). 2. The aim of the present study was to determine whether BF was effective in decreasing visceral adiposity and insulin resistance. Eighty-one Japanese women (body mass index (BMI) 36.5 +/- 4.8 kg/m2) with IGT and insulin resistance (IR), who had been treated with a low-calorie diet (5016 kj/day: 1200 kcal) and an exercise regimen (1254 kj/day: 300 kcal), were randomized to receive either placebo (n=40) or BF treatment (n=41) three times a day. 3. After 24 weeks treatment, the BF group lost significantly (P <0.01) more bodyweight and abdominal visceral fat without a decrease in the adjusted resting metabolic rate (RMR), whereas the placebo group lost bodyweight (P <0.05) and had no significant change in abdominal visceral fat. The BF group had a lower fasting serum insulin level (P <0.05), a lower insulin area under the curve (P <0.05) and a lower level of the homeostasis model assessment of insulin resistance (P <0.01) compared with values before treatment. 4. We conclude that BF could be a useful herbal medicine in treating obesity with IGT.Keywords
This publication has 26 references indexed in Scilit:
- Visceral Adiposity and the Risk of Impaired Glucose ToleranceDiabetes Care, 2003
- An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra–caffeine weight loss product in healthy overweight adultsInternational Journal of Obesity, 2002
- Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trialInternational Journal of Obesity, 2002
- Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescentsInternational Journal of Obesity, 2000
- Association of a Polymorphism in the β3-Adrenergic–Receptor Gene with Features of the Insulin Resistance Syndrome in FinnsNew England Journal of Medicine, 1995
- Insulin resistance in adipocytes of obese women: Effects of body fat distribution and raceMetabolism, 1995
- Visual Impairment and Retinopathy in People With Normal Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed NIDDMDiabetes Care, 1991
- Abdominal Obesity and Physical Inactivity as Risk Factors for NIDDM and Impaired Glucose Tolerance in Indian, Creole, and Chinese MauritiansDiabetes Care, 1991
- Glucose Intolerance and Insulin Resistance Accompany ImmobilizationActa Medica Scandinavica, 1987
- CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall StudyThe Lancet, 1980